PDGFRA and myocardial infarction: Delivery of hTERTmut + PDGFRα + cMSCs failed to increase cardiac function or decrease scar formation after MI, in contrast to the improvements seen with delivery of catalytically active hTERT + PDGFRα + cMSCs.